Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

TALVEY

TALQUETAMAB-TGVS

Standard Dose
3MG/1.5ML(2MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview TALVEY is listed in Drugs@FDA under application 761342 (BLA).

Review priority: N/A Marketing status: Prescription Active ingredient TALQUETAMAB-TGVS Form and strength INJECTABLE;INJECTION - 3MG/1.5ML(2MG/ML) Sponsor JANSSEN BIOTECH Submission history Latest submission status date: 2026-03-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview TALVEY is listed in Drugs@FDA under application 761342 (BLA). Review priority: N/A Marketing status: Prescription Active ingredient TALQUETAMAB-TGVS Form and strength INJECTABLE;INJECTION - 3MG/1.5ML(2MG/ML) Sponsor JANSSEN BIOTECH Submission history Latest submission status date: 2026-03-05 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.